Peter Mu-Hsin Chang
Peter Mu-Hsin Chang
https://bps.nycu.edu.tw/en/faculty-members/
Research Field
Medicine
Introduction
- 2002-2008 Resident doctor of Taipei Veterans General Hospital, Department on Medicine
- 2008- Attending physician of Taipei Veterans General Hospital, Division of Hematology and Oncology
- 2013- Assistant professor, Faculty of Medicine, National Yang Ming University
- 2015-2016 Visiting Scholar, Department of Chemical and Systems Biology, Stanford University
- 2015- current Attending physician of Taipei Veterans General Hospital, Department of Oncology
- 2018- current Associate professor, Faculty of Medicine, National Yang Ming Chiao Tung University
- 2023- current Associate professor, Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University
My lab is at the Yang-Ming campus (Taipei) of National Yang Chiao Tung University. My academic expertise is in tumor drug resistance, clinical human trials, drug development, anti-cancer drug development, oncology. Welcome to my lab.
Research Topics
Clinical Oncology: Head and neck cancer, nasopharyngeal cancer, genitourinary cancer, cancer of unknown primary
New drug development: Preclinical drug target identification, compound selection, clinical trials for anti-cancer indications
Honor
- The 3rd Stanford-Taiwan ALDH2 Deficiency Research (STAR) Consortium Symposium, National Taiwan University Medical College, July 29th , 2017 (Invited Speaker)
- IO Forum for Head and Neck Cancer, Taiwan Head and Neck Society, October 28th, 2017 (Invited Speaker)
- 2018 Molecular Tumor Board: How Comprehensive Genomics Profiling Unlocks Treatment Opportunity (Invited Speaker, first tumor board hosted by Foundation Medicine in Taiwan)
- 14th Annual Meeting of Taiwan Head and Neck Society in conjunction with 2021 Ji-Chuan Yang H&N lecture (Invited Speaker & Panelist)
Educational Background
- Department of Medicine, National Cheng Kung University Medical College, M.D.
- Institute of Clinical Medicine, National Yang Ming University, Ph.D.